Drugs commonly associated with weight change: Umbrella systematic review and meta-analysis (Protocol)

Systematic Reviews

Volumn 1, Issue 1, 2012, Pages

  Domecq, Juan P ^a,b   Prutsky, Gabriela ^a,b   Wang, Zhen ^a   Elraiyah, Tarig ^a   Brito, Juan P ^a   Mauck, Karen ^a   Lababidi, Mohammed H ^a   Leppin, Aaron ^a   Fidahussein, Salman ^a   Prokop, Larry J ^a   Montori, Victor M ^a,b   Murad, Mohammad H ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

Adults; Drug; Leptogenic; Obesogenic; Systematic review; Weight change; Weight gain; Weight loss

Indexed keywords

4 HYDROXYBUTYRIC ACID; ACARBOSE; AMFEBUTAMONE; AMITRIPTYLINE; ARIPIPRAZOLE; ATENOLOL; BROMOCRIPTINE; CABERGOLINE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; DOXAZOSIN MESYLATE; DOXEPIN; DULOXETINE; ESCITALOPRAM; EXENDIN 4; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GROWTH HORMONE; LAMOTRIGINE; LEUPRORELIN; LIRAGLUTIDE; LITHIUM; METFORMIN; METOPROLOL; MIGLITOL; NEFAZODONE; OCTREOTIDE; UNINDEXED DRUG;

ARTICLE; BODY MASS; FOLLOW UP; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SYSTEMATIC REVIEW; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; BODY WEIGHT; DRUG EFFECT; LITERATURE; META ANALYSIS (TOPIC); METHODOLOGY;

BODY MASS INDEX; BODY WEIGHT; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC; WEIGHT GAIN; WEIGHT LOSS;

MLCS; MLOWN;

EID: 84876195864     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-1-44     Document Type: Article

References (23)

1. Barness LA, Opitz JM, Gilbert-Barness E. Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A 2007, 143A:3016-3034. 10.1002/ajmg.a.32035, 18000969.
2. Vasan RS, Pencina MJ, Cobain M, Freiberg MS, D'Agostino RB. Estimated risks for developing obesity in the Framingham Heart Study. Ann Intern Med 2005, 143:473-480.
3. World Health Organization Obesity and overweight. Fact sheets. Book Obesity and overweight. Fact sheets 2011, WHO, Geneva, World Health Organization.
4. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037. 10.1001/jama.298.17.2028, 17986696.
5. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009, 373:1083-1096. 10.1016/S0140-6736(09)60318-4, 2662372, 19299006.
6. Preston SH, Stokes A. Contribution of obesity to international differences in life expectancy. Am J Public Health 2011, 101:2137-2143. 10.2105/AJPH.2011.300219, 3222401, 21940912.
7. Stevens J, Truesdale KP, McClain JE, Cai J. The definition of weight maintenance. Int J Obes (Lond) 2006, 30:391-399.
8. Bjorkhem-Bergman L, Asplund AB, Lindh JD. Metformin for weight reduction in non-diabetic patients on antipsychotic drugs: a systematic review and meta-analysis. J Psychopharmacol 2011, 25:299-305. 10.1177/0269881109353461, 20080925.
9. Borovicka MC, Fuller MA, Konicki PE, White JC, Steele VM, Jaskiw GE. Phenylpropanolamine appears not to promote weight loss in patients with schizophrenia who have gained weight during clozapine treatment. J Clin Psychiatry 2002, 63:345-348. 10.4088/JCP.v63n0412, 12000209.
10. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007, (1):CD005148.
11. Jaeschke R. Understanding the Results: More about Odss Ratios. User's guides to the medical Literature A manual for Evidence-Based Clinical Practice 2008, 221-230. The McGraw-Hill Companies, Inc, Guyatt GH.
12. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ 2001, 165:1339-1341. 81628, 11760981.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
15. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Book Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, Oxford.
16. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
17. Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ 2006, 333:597-600. 10.1136/bmj.333.7568.597, 1570006, 16974018.
18. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004, 291:2457-2465. 10.1001/jama.291.20.2457, 15161896.
19. Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, Williamson PR. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010, 340:c365. 10.1136/bmj.c365, 20156912.
20. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med 2005, 24:2401-2428. 10.1002/sim.2112, 16015676.
21. Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Imputing missing standard deviations in meta-analyses can provide accurate results. J Clin Epidemiol 2006, 59:7-10. 10.1016/j.jclinepi.2005.06.006, 16360555.
22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-e34. 10.1016/j.jclinepi.2009.06.006, 19631507.
23. Swiglo BA, Murad MH, Schunemann HJ, Kunz R, Vigersky RA, Guyatt GH, Montori VM. A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 2008, 93:666-673.